Cardiovascular Drugs Practice Questions

Q: Which of the following drugs is commonly responsible for orthostatic hypotension?

Prazosin. **Explanation:** **Prazosin** is the correct answer because it is a highly selective **alpha-1 ($\alpha_1$) adrenergic blocker**. Alpha-1 receptors are primarily located on vascular smooth muscle; blocking them leads to potent vasodilation of both arterioles and veins. When a patient stands up, the normal compensatory sympathetic reflex (vasoconstriction) is inhibited, leading to a sudden drop in blood pressure. This is famously known as the **"First-Dose Phenomenon,"** where severe orthostatic hypotension and syncope occur shortly after the initial dose. **Analysis of Incorrect Options:** * **Clonidine:** This is a central $\alpha_2$ agonist. While it reduces sympathetic outflow, it is more commonly associated with sedation and **rebound hypertension** upon abrupt withdrawal rather than significant orthostatic hypotension. * **Hydralazine:** A direct-acting arteriolar vasodilator. Because it does not affect the venous side (capacitance vessels) or the sympathetic reflex arc, it typically causes **reflex tachycardia** and fluid retention rather than postural hypotension. * **Captopril:** An ACE inhibitor. While it can cause a "first-dose effect" (especially in volume-depleted patients), it does not interfere with the sympathetic nervous system's baroreceptor reflex, making orthostatic hypotension less common than with alpha-blockers. **High-Yield Clinical Pearls for NEET-PG:** * **First-Dose Phenomenon:** To minimize this risk with Prazosin, advise patients to take the first dose at **bedtime** and start with a low dose. * **BPH:** Selective $\alpha_1$ blockers (like Tamsulosin) are preferred for Benign Prostatic Hyperplasia as they target $\alpha_{1A}$ receptors in the bladder neck with less effect on systemic blood pressure. * **Drug of Choice:** Prazosin is also used in the treatment of Raynaud’s phenomenon and scorpion sting (red scorpion) poisoning.

Q: What is the agent of first choice in an acute attack of Prinzmetal's angina?

Nitrates. **Explanation:** **Prinzmetal’s Angina (Variant Angina)** is caused by a sudden, intense coronary artery vasospasm rather than fixed atherosclerotic obstruction. **1. Why Nitrates are the First Choice:** In an **acute attack**, the primary goal is immediate vasodilation to relieve the spasm. **Sublingual Nitroglycerin (Nitrates)** is the agent of choice because it acts as a potent smooth muscle relaxant [2]. Nitrates are converted into Nitric Oxide (NO), which increases cGMP levels, leading to rapid coronary vasodilation and immediate relief of the ischemic pain. **2. Analysis of Incorrect Options:** * **Diltiazem & Verapamil (Calcium Channel Blockers):** While CCBs are the **drugs of choice for long-term prophylaxis** (prevention) of Prinzmetal’s angina, they are not the first choice for an *acute* attack because their onset of action is slower compared to sublingual nitrates [1]. * **Propranolol (Beta-blockers):** These are **strictly contraindicated** in Prinzmetal’s angina. Blocking $\beta_2$ receptors (which cause vasodilation) leaves $\alpha_1$ receptors unopposed, leading to further vasoconstriction and worsening of the coronary spasm. **3. NEET-PG High-Yield Pearls:** * **Drug of choice for Acute Attack:** Sublingual Nitrates [2]. * **Drug of choice for Chronic Prophylaxis:** Calcium Channel Blockers (e.g., Nifedipine, Diltiazem, Verapamil) [1], [3]. * **Contraindicated Drug:** Non-selective Beta-blockers (Propranolol). * **ECG Finding:** Transient ST-segment **elevation** (unlike stable angina, which shows ST-depression). * **Trigger:** Often occurs at rest, typically in the early morning hours.

Q: Nitroglycerine exerts beneficial effects in variant angina primarily by:

Coronary vasodilation. **Explanation:** The primary pathology in **Variant (Prinzmetal) Angina** is a sudden, intense spasm of the coronary arteries rather than fixed atherosclerotic obstruction. This leads to transmural ischemia and ST-segment elevation. **1. Why Option A is Correct:** Nitroglycerine (NTG) acts as a prodrug that releases **Nitric Oxide (NO)**, stimulating guanylyl cyclase and increasing cGMP levels. This leads to dephosphorylation of myosin light chains and relaxation of smooth muscle. In variant angina, the therapeutic goal is to reverse the acute vasospasm. NTG directly causes **coronary vasodilation**, increasing oxygen supply to the myocardium and effectively terminating the spasm. **2. Why Other Options are Incorrect:** * **Option B:** Nitrates do not have a direct negative inotropic effect; they do not decrease ventricular contractility. * **Options C & D:** While reduction of preload (venodilation) and afterload (arteriolar dilation) are the primary mechanisms by which nitrates benefit **Stable Angina** (by reducing myocardial oxygen demand), they are secondary effects in variant angina. In the specific context of a coronary spasm, restoring blood flow via direct vasodilation is the definitive beneficial action. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** For acute attacks of variant angina, **Sublingual Nitroglycerine** is used. For long-term prophylaxis, **Calcium Channel Blockers (CCBs)** are the drugs of choice. * **Contraindication:** **Non-selective Beta-blockers** (e.g., Propranolol) are contraindicated in variant angina as they can worsen spasms due to unopposed alpha-adrenergic activity. * **Monday Disease:** Refers to nitrate tolerance and withdrawal symptoms (tachycardia, dizziness) seen in industrial workers exposed to nitrates.

Q: Which of the following drugs does not act by blocking Gp IIb/IIIa receptors?

Clopidogrel. **Explanation:** The question tests the classification of antiplatelet agents based on their mechanism of action. **1. Why Clopidogrel is the correct answer:** Clopidogrel is a **P2Y12 receptor antagonist**. It works by irreversibly inhibiting the ADP (Adenosine Diphosphate) receptor on the platelet surface. This inhibition prevents the activation of the Gp IIb/IIIa receptor complex, thereby inhibiting platelet aggregation. It does **not** bind directly to the Gp IIb/IIIa receptor itself. **2. Why the other options are incorrect:** Options A, B, and C are all direct **Gp IIb/IIIa inhibitors**, often referred to as the "final common pathway" inhibitors of platelet aggregation: * **Abciximab (A):** A chimeric monoclonal antibody fragment that binds irreversibly to Gp IIb/IIIa receptors. * **Eptifibatide (B):** A cyclic peptide that acts as a reversible competitive inhibitor (derived from rattlesnake venom). * **Tirofiban (C):** A non-peptide small molecule that acts as a reversible competitive inhibitor. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Gp IIb/IIIa receptors normally bind to **fibrinogen** and von Willebrand factor to form cross-links between platelets. * **Route of Administration:** All Gp IIb/IIIa inhibitors are administered **intravenously**, whereas Clopidogrel is administered **orally**. * **Side Effects:** The most significant side effect of Gp IIb/IIIa inhibitors is bleeding and **thrombocytopenia** (especially with Abciximab). * **Clopidogrel Metabolism:** It is a **prodrug** activated by the hepatic enzyme **CYP2C19**. Drugs like Omeprazole can inhibit this enzyme, reducing Clopidogrel's efficacy.

Q: Fenoldopam is used in which of the following conditions?

Hypertensive emergencies. **Explanation:** **Fenoldopam** is a unique pharmacological agent that acts as a **selective post-synaptic Dopamine-1 (D1) receptor agonist**. Its primary clinical utility lies in the management of **Hypertensive Emergencies** (Option A). **Why Option A is Correct:** Activation of D1 receptors leads to potent **arteriolar vasodilation** and a reduction in peripheral vascular resistance. A key feature of Fenoldopam is its ability to cause **renal vasodilation**, which increases renal blood flow and promotes **natriuresis** (sodium excretion) and diuresis. This makes it particularly beneficial for hypertensive patients with concomitant renal impairment, as it maintains organ perfusion while lowering blood pressure. **Why Other Options are Incorrect:** * **B. Orthostatic Hypotension:** This condition requires vasopressors (like Midodrine) or volume expanders. Fenoldopam, being a vasodilator, would worsen hypotension. * **C. Congestive Heart Failure (CHF):** While vasodilators are used in CHF, Fenoldopam is not a standard treatment. Inotropes (like Dobutamine) or ACE inhibitors are preferred. * **D. Angina:** Nitrates and Beta-blockers are the mainstays. Fenoldopam may cause reflex tachycardia, which increases myocardial oxygen demand and could exacerbate angina. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Administered via continuous intravenous infusion due to a short half-life (~5–10 minutes). * **Unique Benefit:** It is the only parenteral antihypertensive that improves renal perfusion. * **Side Effects:** Headache, flushing, and a dose-dependent increase in **intraocular pressure** (use with caution in glaucoma). * **Comparison:** Unlike Sodium Nitroprusside, Fenoldopam does not carry the risk of cyanide toxicity.

Q: Which of the following agents is a Neprilysin inhibitor?

Sacubitril. **Explanation:** **Sacubitril** is a prodrug that, upon activation to sacubitrilat, inhibits the enzyme **Neprilysin** (neutral endopeptidase). Neprilysin is responsible for the degradation of endogenous vasoactive peptides, including Atrial Natriuretic Peptide (ANP), B-type Natriuretic Peptide (BNP), and bradykinin. By inhibiting this enzyme, Sacubitril increases the levels of these peptides, leading to vasodilation, natriuresis, and diuresis, which counteracts the maladaptive vasoconstriction and fluid retention seen in heart failure. **Analysis of Incorrect Options:** * **Carperitide:** This is a recombinant form of human **Atrial Natriuretic Peptide (ANP)**. It acts as an agonist at natriuretic peptide receptors, not as an enzyme inhibitor. * **Neseritide:** This is a recombinant form of human **B-type Natriuretic Peptide (BNP)** used in acute decompensated heart failure. Like Carperitide, it is a peptide analog, not a neprilysin inhibitor. * **Ularitide:** This is a synthetic form of **Urodilatin** (a natriuretic peptide produced in the kidneys). It also functions as a receptor agonist. **High-Yield Clinical Pearls for NEET-PG:** * **ARNI:** Sacubitril is clinically used in a fixed-dose combination with Valsartan (an ARB), known as an **Angiotensin Receptor-Neprilysin Inhibitor (ARNI)**. * **Indication:** It is a first-line therapy for Heart Failure with Reduced Ejection Fraction (HFrEF) to reduce mortality and hospitalizations. * **Contraindication:** It must **not** be administered with an ACE inhibitor due to a significantly increased risk of **angioedema** (both drugs prevent the breakdown of bradykinin). A washout period of **36 hours** is required when switching from an ACE inhibitor to an ARNI.

Q: Combination use of beta blockers and calcium channel blockers can cause which of the following?

All of these. ### Explanation The combination of **Beta-blockers (BBs)** and **Calcium Channel Blockers (CCBs)**, particularly the non-dihydropyridines like **Verapamil** and **Diltiazem**, is generally avoided or used with extreme caution due to their synergistic inhibitory effects on the heart. **Why "All of these" is correct:** Both BBs and non-dihydropyridine CCBs exert negative inotropic (force), negative chronotropic (rate), and negative dromotropic (conduction) effects. 1. **Heart Block:** Both drug classes depress the **Atrioventricular (AV) node**. When combined, they significantly prolong the PR interval, which can progress to complete heart block. 2. **Bradycardia:** Both classes suppress the **Sinoatrial (SA) node** firing rate. Their additive effect can lead to severe sinus bradycardia. 3. **Hypotension:** BBs reduce cardiac output, while CCBs cause peripheral vasodilation and further reduce myocardial contractility. Together, they can lead to a profound drop in blood pressure. **Evaluation of Options:** * **A, B, and C** are all individual physiological consequences of the combined pharmacodynamic profile of these drugs. Since all three occur simultaneously or as part of the same clinical picture, "All of these" is the most comprehensive answer. **High-Yield Clinical Pearls for NEET-PG:** * **The "Verapamil Rule":** Intravenous Verapamil is strictly contraindicated in patients already taking Beta-blockers due to the high risk of asystole. * **Dihydropyridines (e.g., Amlodipine):** These are safer to combine with BBs because they primarily cause vasodilation and may even trigger reflex tachycardia, which BBs help counteract. * **Antidote:** In cases of toxicity from this combination, **Glucagon** is the drug of choice as it increases cAMP levels in the heart via non-adrenergic pathways, bypassing the blocked receptors.

Q: Which of the following is not a centrally acting hypertensive agent?

Minoxidil. **Explanation:** The question asks to identify the drug that does **not** act via the central nervous system to lower blood pressure. **1. Why Minoxidil is the Correct Answer:** Minoxidil is a **direct-acting peripheral vasodilator**. Its mechanism of action involves opening **ATP-sensitive potassium channels ($K_{ATP}$)** in vascular smooth muscle. This leads to potassium efflux, hyperpolarization, and subsequent relaxation of arterioles (not veins). Because it acts directly on the blood vessels and not the brain, it is not a centrally acting agent. **2. Analysis of Incorrect Options (Centrally Acting Agents):** * **Clonidine:** A prototypical central **$\alpha_2$-adrenergic agonist**. It stimulates $\alpha_2$ receptors in the nucleus tractus solitarius (NTS), decreasing sympathetic outflow from the vasomotor center. * **Methyldopa:** A prodrug converted to $\alpha$-methylnorepinephrine in the brain. It acts as a central **$\alpha_2$ agonist**, making it the drug of choice for hypertension in pregnancy. * **Moxonidine:** A selective **imidazoline $I_1$ receptor agonist** in the rostral ventrolateral medulla. It reduces sympathetic activity with fewer sedative side effects than clonidine. **3. NEET-PG High-Yield Pearls:** * **Minoxidil Side Effects:** Significant reflex tachycardia and salt/water retention (usually co-prescribed with a beta-blocker and diuretic). It also causes **hypertrichosis** (used topically for alopecia). * **Clonidine Withdrawal:** Abrupt cessation leads to a **rebound hypertensive crisis** due to a sudden surge in catecholamines. * **Methyldopa Side Effect:** Can cause a **positive Coombs test** and rare hemolytic anemia.

Question 1

Which of the following drugs is commonly responsible for orthostatic hypotension?

Accepted Answer

Prazosin

Answer

Clonidine

Answer

Hydralazine

Answer

Captopril

Question 2

What is the agent of first choice in an acute attack of Prinzmetal's angina?

Accepted Answer

Nitrates

Answer

Diltiazem

Answer

Propranolol

Answer

Verapamil

Question 3

"Monday disease" is seen with which of the following?

Accepted Answer

Isosorbide mononitrate

Answer

Calcium channel blockers

Answer

Benzodiazepines

Answer

Chlorpromazine

Question 4

Nitroglycerine exerts beneficial effects in variant angina primarily by:

Accepted Answer

Coronary vasodilation

Answer

Decreased ventricular contractility

Answer

Reduction of cardiac preload

Answer

Reduction of cardiac afterload

Question 5

Which of the following drugs does not act by blocking Gp IIb/IIIa receptors?

Accepted Answer

Clopidogrel

Answer

Abciximab

Answer

Eptifibatide

Answer

Tirofiban

Question 6

ACE inhibitors are contraindicated in bilateral renal artery stenosis, because:

Accepted Answer

Angiotensin II has a direct effect on GFR

Answer

They enhance bradykinin action

Answer

Hyperreninism affects renal parenchyma

Answer

They affect prostaglandins

Question 7

Fenoldopam is used in which of the following conditions?

Accepted Answer

Hypertensive emergencies

Answer

Orthostatic hypotension

Answer

Congestive heart failure (CHF)

Answer

Angina

Question 8

Which of the following agents is a Neprilysin inhibitor?

Accepted Answer

Sacubitril

Answer

Carperitide

Answer

Neseritide

Answer

Ularitide

Question 9

Combination use of beta blockers and calcium channel blockers can cause which of the following?

Accepted Answer

All of these

Answer

Heart block

Answer

Hypotension

Answer

Bradycardia

Question 10

Which of the following is not a centrally acting hypertensive agent?

Accepted Answer

Minoxidil

Answer

Methyldopa

Answer

Moxonidine

Answer

Clonidine

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?